Respiratory News and Research

RSS

Research reveals how Mycoplasma pathogens sneak past our line of defense

New research reveals that Mycoplasma pathogens make DNA in a unique way that may protect them from our immune response. The result could provide new avenues to combat the pathogens that utilize this strategy.

1 Nov 2018

Goethe University plays important role in rare disease research

Patients with rare diseases often go through a long history of suffering before finally receiving an accurate diagnosis.

31 Oct 2018

Brain may have more influence on lifespan and sexual maturity of humans than their body

New Vanderbilt research finds how long humans and other live--and when they reach sexual maturity-- may have more to do with their brain than their body. More specifically, it is not animals with larger bodies or slower metabolic rates that live longer; it is animals with more neurons in the cerebral cortex, whatever the size of the body.

31 Oct 2018

Air pollution kills 600,000 children with India being worst affected says WHO

A report from the World Health Organisation (WHO) says that air pollution is responsible for killing nearly 600,000 children every year. Among millions of other children affected with the effects of air pollution it leads to severe symptoms of various conditions such as asthma, respiratory diseases, loss of intelligence, excessive weight gain and ear infections.

31 Oct 2018

Teleflex wins 2018 Medical Design Excellence Award for Arrow AC3 Optimus Intra-Aortic Balloon Pump

Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, is proud to announce the Arrow AC3 Optimus Intra-Aortic Balloon Pump, has been selected as the bronze winner in the cardiovascular device category of the 20th annual Medical Design Excellence Awards competition.

29 Oct 2018

Toxic effects of drugs in the lungs 'more widespread than thought'

A systematic review of research has revealed that the toxic effects on the lung of drugs commonly taken to treat a range of common conditions is much more widespread than thought.

29 Oct 2018

Air pollution is the new tobacco says WHO Head

The head of the World Health Organization has said that air pollution is the “new tobacco” and breathing polluted air is killing 7 million people annually and harming billions of the population additionally.

29 Oct 2018

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

The neurologic effects and treatment options for exposure to biologic and chemical agents are outlined in a newly published article by neurologists from the University of Colorado School of Medicine who collaborated on the article with military physicians.

26 Oct 2018

Influenza virus can evolve resistance to experimental antiviral drug

The influenza virus can evolve resistance to an anti-flu drug currently in development for use in pandemics but only if there are multiple genetic mutations, a study has found.

25 Oct 2018

New genetic pathways associated with severe lung disease identified in extremely premature infants

Scientists from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago and colleagues identified promising new genetic pathways associated with severe lung disease in extremely premature infants, as well as pathways linked to faster recovery from lung disease in this population.

25 Oct 2018

Loss of serotonin neuron activity blunts the body’s ability to recover from interrupted breathing

Scientists trying to identify the roots of sudden infant death syndrome, the leading cause of death in U.S. infants between 1 month and 1 year old, have increasingly turned their attention to the neurotransmitter serotonin and the brain cells that produce it.

25 Oct 2018

FDA approves new antiviral flu treatment

Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

24 Oct 2018

New vaccine strategy shows promise to protect chickens against serious respiratory disease

A new vaccine strategy could offer protection to millions of chickens threatened by a serious respiratory disease, research shows.

23 Oct 2018

Study uncovers new mechanism of action in a first-line drug for diabetes

For decades, metformin has been the first-line drug in the treatment of type 2 diabetes, lowering blood glucose levels by inhibiting glucose production in the liver. Metformin also improves glucose uptake and use by muscle tissue.

23 Oct 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

Patients with severe asthma may benefit from newly developed targeted treatments

In a novel study, researchers succeeded in identifying patients with a form of severe asthma (type 2 endotype) by measuring periostin concentrations in their airways.

23 Oct 2018

Duration of respiratory disturbances may better predict mortality risk from OSA

How long a person with obstructive sleep apnea stops breathing may be a better predictor of mortality risk from OSA than the number of times they stop breathing, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.

22 Oct 2018

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Bristol-Myers Squibb Company today announced four-year data from the Phase 3 CheckMate -067 clinical trial - the longest follow-up to date - which continues to demonstrate durable, long-term survival benefits with the first-line combination of Opdivo (nivolumab) and Yervoy (ipilimumab), versus Yervoy alone, in patients with advanced melanoma.

22 Oct 2018

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING (stimulator of interferon genes) agonist, as monotherapy and in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas.

22 Oct 2018

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.

22 Oct 2018

Respiratory News and Research

Research reveals how Mycoplasma pathogens sneak past our line of defense

Goethe University plays important role in rare disease research

Brain may have more influence on lifespan and sexual maturity of humans than their body

Air pollution kills 600,000 children with India being worst affected says WHO

Teleflex wins 2018 Medical Design Excellence Award for Arrow AC3 Optimus Intra-Aortic Balloon Pump

Toxic effects of drugs in the lungs 'more widespread than thought'

Air pollution is the new tobacco says WHO Head

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

Influenza virus can evolve resistance to experimental antiviral drug

New genetic pathways associated with severe lung disease identified in extremely premature infants

Loss of serotonin neuron activity blunts the body’s ability to recover from interrupted breathing

FDA approves new antiviral flu treatment

New vaccine strategy shows promise to protect chickens against serious respiratory disease

Study uncovers new mechanism of action in a first-line drug for diabetes

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Patients with severe asthma may benefit from newly developed targeted treatments

Duration of respiratory disturbances may better predict mortality risk from OSA

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News